Sign In
Buy NVTA
$0.0190
+0 (+0%)
At Close: May 13, 2024
Invitae to Present at the William Blair 41st Annual Growth Stock Conference
07:30am, Thursday, 20'th May 2021
SAN FRANCISCO, May 20, 2021 /PRNewswire/ -- Invitae Corporation (NYSE: NVTA), a leading medical genetics company, today announced that members of its management team will present at the William Blai
Here's What Stood Out With Invitae's Q1 Results
06:04am, Thursday, 13'th May 2021
It wasn't just the genetics company's soaring revenue growth.
Invitae (NVTA) Outpaces Stock Market Gains: What You Should Know
06:47pm, Friday, 07'th May 2021
Invitae (NVTA) closed at $29.95 in the latest trading session, marking a +1.66% move from the prior day.
Invitae CEO on the importance of genetic testing for preventative care
02:43pm, Wednesday, 05'th May 2021
Invitae CEO Sean George joins "Power Lunch" to discuss genetic testing and what health care looks like after the pandemic.
Here's Why Invitae's Q1 Revenue Soared 61%
06:05am, Wednesday, 05'th May 2021
Sales were strong, but the medical genetics company still missed analysts' bottom-line expectations.
Invitae Corporation's (NVTA) CEO Sean George on Q1 2021 Results - Earnings Call Transcript
12:01am, Wednesday, 05'th May 2021
Invitae Corporation's (NVTA) CEO Sean George on Q1 2021 Results - Earnings Call Transcript
Recap: Invitae Q1 Earnings
04:55pm, Tuesday, 04'th May 2021
Shares of Invitae (NYSE:NVTA) decreased in after-market trading after the company reported Q1 results. Quarterly Results Earnings per share rose 21.25% over the past year to ($0.63), which missed the
Invitae: Beware Of The Hype
04:18pm, Monday, 03'rd May 2021
Invitae's supposed market leadership in genetic testing is not reflected in its declining revenue growth trend and gross margin.
Earnings Previews: Activision Blizzard, Devon Energy, Invitae, Lyft, Skillz
11:31am, Monday, 03'rd May 2021
More than 1,500 publicly traded companies are scheduled to report March quarter earnings this week, with heavy representation from energy exploration and production companies.
Invitae (NVTA) Dips More Than Broader Markets: What You Should Know
07:02pm, Wednesday, 28'th Apr 2021
Invitae (NVTA) closed at $36.66 in the latest trading session, marking a -1.5% move from the prior day.
Invitae to Open New Facility in North Carolina to Support Continued Growth
04:05pm, Tuesday, 20'th Apr 2021
SAN FRANCISCO, April 20, 2021 /PRNewswire/ -- Invitae Corporation (NYSE: NVTA), a leading medical genetics company, today announced its plans to open a new laboratory and production facility in North
AstraZeneca, Loxo Oncology at Lilly, and Invitae Corporation Join the Access to Comprehensive Genomic Profiling Coalition
10:00am, Monday, 19'th Apr 2021
WASHINGTON, April 19, 2021 /PRNewswire/ -- The Access to Comprehensive Genomic Profiling Coalition (ACGP) announced today the addition of AstraZeneca, Loxo Oncology at Lilly, and Invitae Corporation
Is Invitae a Buy?
07:15am, Saturday, 17'th Apr 2021
Can this leading clinical gene testing company add muscle to your portfolio?
Study finds risk-causing genetic changes in nearly 1 in 6 patients with colorectal cancer
07:30am, Thursday, 15'th Apr 2021
SAN FRANCISCO, April 15, 2021 /PRNewswire/ -- Invitae Corporation (NYSE: NVTA), a leading medical genetics company, today announced research showing one in six people with colorectal cancer harbor ge
Invitae (NVTA) Dips More Than Broader Markets: What You Should Know
06:59pm, Wednesday, 14'th Apr 2021
In the latest trading session, Invitae (NVTA) closed at $39.07, marking a -0.79% move from the previous day.
